ArticleThe oncologist2025
Correction to: Efficacy and Safety of Camrelizumab, Apatinib, and Capecitabine Combination Therapy in Advanced Biliary Tract Cancer: A Single-arm Prospective Study.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.